BRIEF published on 10/31/2025 at 18:05, 1 month 14 days ago 2025 Half-Year Results: Aton Confirms its Recovery Financial Recovery 2025 Results PIMS Technology Inoviem Scientific B Cell Design
BRIEF published on 10/08/2025 at 18:05, 2 months 6 days ago Strategic partnership between Inoviem Scientific and abc biopply in preclinical oncology Strategic Partnership 3D Models Therapeutic Innovation Preclinical Oncology Translational Pharmacology
BRIEF published on 09/29/2025 at 08:05, 2 months 16 days ago ATON Presents its New Strategy at the European MidCap Event 2025 Investors Governance Financial Strategy Aton European MidCap
BRIEF published on 09/17/2025 at 18:05, 2 months 27 days ago PIMS Technology secures €500,000 in funding from Bpifrance Funding Marketing Precision Medicine Bpifrance PIMS Technology
BRIEF published on 09/10/2025 at 18:10, 3 months 4 days ago Strategic partnership between Logical Biological and B Cell Design Public Health Strategic Partnership Technological Innovation Medical Diagnosis Monoclonal Antibodies
BRIEF published on 09/03/2025 at 18:05, 3 months 11 days ago ATON SA: New Phase of Valorization of its Technological Assets Financial Results Life Sciences Videoconferencing Technological Development ATON SA
BRIEF published on 04/30/2025 at 18:05, 7 months 14 days ago Financial Improvement for Aton in 2024 Financial Results Restructuring Future Development Aton Medical Societies
BRIEF published on 10/31/2024 at 18:05, 1 year 1 month ago Promising 2024 half-year results for Aton Sustainable Growth Cost Reduction Half-year Results Financial Restructuring Consolidation Of Assets
BRIEF published on 10/01/2024 at 18:35, 1 year 2 months ago Combined general meeting of September 30, 2024: Approval of the 2023 annual accounts and resolutions General Meeting Resolutions Financial Restructuring Aton Administrators
BRIEF published on 07/18/2024 at 18:05, 1 year 4 months ago Aton successfully finalizes its financial restructuring Treasury Financial Restructuring Increase In Capital Deleveraging Lock-up
Published on 12/15/2025 at 15:00, 1 hour 8 minutes ago Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 1 hour 8 minutes ago Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 1 hour 38 minutes ago Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 2 hours 8 minutes ago Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum
Published on 12/15/2025 at 13:30, 2 hours 38 minutes ago Greenlane Announces Results of Annual Meeting of Stockholders, Canopy Growth Co Founder Bruce Linton Joins Greenlane's Board of Directors
Published on 12/15/2025 at 15:50, 17 minutes ago Original-Research: Cabka N.V. (von First Berlin Equity Research GmbH): Kaufen
Published on 12/15/2025 at 15:49, 18 minutes ago Mutares submits an irrevocable offer to acquire Venator Ultramarine Blue Pigments business from Venator France SAS
Published on 12/15/2025 at 15:45, 22 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 12/15/2025 at 15:44, 23 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/15/2025 at 15:43, 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 12/15/2025 at 11:50, 4 hours 18 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 22 hours ago Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/11/2025 at 08:30, 4 days 7 hours ago Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe
